SEC 13F Intelligence

Vivo Capital, LLC / ORIC

Vivo Capital, LLC’s Oric Pharmaceuticals Inc Position

Does Vivo Capital, LLC own Oric Pharmaceuticals Inc (ORIC)? Yes — 1.85M shares worth $23M (+1.95% of its 13F portfolio) as of Q1 2026, down from 2.12M shares the prior filed quarter.

Position Value
$23M
Q1 2026
Shares
1.85M
% of Portfolio
+1.95%
Quarters Held
11
currently held

Position History ORIC

Reported value by quarter
Q3 ’23: $5MQ3 ’23Q4 ’23: $8MQ1 ’24: $12MQ1 ’24Q2 ’24: $9MQ3 ’24: $13MQ3 ’24Q4 ’24: $10MQ1 ’25: $12MQ1 ’25Q2 ’25: $32MQ3 ’25: $38MQ3 ’25Q4 ’25: $17MQ1 ’26: $23MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.85M$23M+1.95%
Q4 20252.12M$17M+1.12%
Q3 20253.13M$38M+3.02%
Q2 20253.13M$32M+3.25%
Q1 20252.08M$12M+1.54%
Q4 20241.28M$10M+1.16%
Q3 20241.28M$13M+1.08%
Q2 20241.27M$9M+0.83%
Q1 2024849.7K$12M+0.92%
Q4 2023849.7K$8M+0.64%
Q3 2023777.9K$5M+0.52%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vivo Capital, LLC’s full portfolio or all institutional holders of ORIC.